Időskori makuladegeneráció: vizsgálatok itt: Németország

In Németország 22 Also abroad 218

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Where
Bonn, Freiburg im Breisgau, Hanover, Heidelberg, Neubrandenburg, Tübingen, Ulm
Életkor
55 év to 64 év
People
110 worldwide
Run by
Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00
2. fázisTaking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Bonn, Ludwigshafen Am Rhein, Munster, Tuebingen
Életkor
50 év and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
3. fázisTaking people
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Where
Chemnitz, Duesseldorf, Goettingen, Hanover, Rostock, Wuerzburg
Életkor
50 év and over
People
250 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00
3. fázisTaking people
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Berlin, Bonn, Duesseldorf, Frankfurt am Main, Goettingen, Hamburg, Heidelberg, Homburg, Ludwigshafen Am Rhein, Mainz, Marburg, Muenster, Munster, Neubrandenburg, Sulzbach, Ulm, Wuerzburg
Életkor
50 év to 85 év
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00
2/3. fázisTaking people
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Where
Bonn, Goettingen, Hanover, Leipzig, Ludwigshafen Am Rhein, Muenster, Munster, Tuebingen
Életkor
60 év and over
People
274 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00
No phaseTaking people
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
Where
Bonn
Életkor
50 év and over
People
1000 worldwide
Run by
University of Wisconsin, Madison
See details and how to joinNCT06924021
3. fázisTaking people
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Berlin, Bonn, Freiburg im Breisgau, Goettingen, Hamburg, Hanover, Ludwigshafen Am Rhein, Luebeck, Muenster, Munich, Tuebingen, Ulm
Életkor
50 év and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00
3. fázisTaking people
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Where
Bonn, Cologne, Cottbus, Freiburg im Breisgau, Hamburg, Ludwigshafen Am Rhein, Muenster, Munich, Munster, Sulzbach, Tuebingen, Ulm
Életkor
50 év and over
People
1000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00
3. fázisTaking people
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Düsseldorf, Frankfurt, Neubrandenburg
Életkor
50 év and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
2/3. fázisTaking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Where
Hamburg, Münster
Életkor
50 év and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07440225
2. fázisCsak meghívásos
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Where
Luebeck, Tuebingen
Életkor
55 év and over
People
225 worldwide
Run by
Gyroscope Therapeutics Limited
See details and how to joinNCT05481827 · EU 2024-510946-15-00
3. fázisTaking people
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
Where
Berlin, Bonn, Hamburg, Ludwigshafen Am Rhein, Muenster, Munich, Stuttgart, Sulzbach, Ulm, Würzburg
Életkor
50 év to 120 év
People
210 worldwide
Run by
King's College Hospital NHS Trust
See details and how to joinNCT04663750 · EU 2023-504751-28-00
2. fázisTaking people
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Where
Aachen, Ahaus, Baden-Baden, Bonn, Duesseldorf, Frankfurt am Main, Marburg, Wuerzburg
Életkor
55 év and over
People
324 worldwide
Run by
ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00
2. fázisTaking people
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Where
Bonn, Giessen, Köln, Mainz, Muenster, Munich, Sulzbach, Tuebingen
Életkor
60 év and over
People
240 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00
No phaseTaking people
Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy
Where
Hamburg, München, Stuttgart, Tübingen, Ulm
Életkor
60 év and over
People
70
Run by
Okuvision GmbH
See details and how to joinNCT07531927
No phaseTaking people
DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.
Where
Leverkusen
Életkor
18 év and over
People
50 000
Run by
Bayer
See details and how to joinNCT07308639
2/3. fázisTaking people
A randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)
Where
Bonn, Frankfurt am Main, Hamburg, Hanover, Munich, Munster, Tuebingen
Életkor
18 év and over
People
130 worldwide
Run by
Eyebiotech Limited
See details and how to join2025-524575-22-00 · EU 2025-524575-22-00
No phaseCsak meghívásos
Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality
Where
Göttingen
Életkor
18 év and over
People
22
Run by
University Medical Center Goettingen
See details and how to joinNCT07529041
No phaseTaking people
Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD
Where
Bonn
Életkor
18 év and over
People
150
Run by
Maximilian Pfau
See details and how to joinNCT07515521
No phaseTaking people
International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
Where
Hamburg, Sulzbach, Trier, Würzburg
Életkor
55 év and over
People
44 worldwide
Run by
VisionCare, Inc.
See details and how to joinNCT07164378
No phaseNot yet taking people in Németország
This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)
Where
Munich
Életkor
18 év and over
People
100
Run by
Johannes Schiefelbein
See details and how to joinNCT06817915
2. fázisCsak meghívásos
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
Where
Bonn, Freiburg im Breisgau, Hamburg, Ludwigshafen Am Rhein, Muenster, Ulm
Életkor
50 év and over
People
865 worldwide
Run by
AbbVie
See details and how to joinNCT03999801 · EU 2023-505750-17-00